- Home
- Publications
- Publication Search
- Publication Details
Title
EAACI Biologicals Guidelines—Recommendations for severe asthma
Authors
Keywords
-
Journal
ALLERGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-06-03
DOI
10.1111/all.14425
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Evolving Algorithm of Biological Selection in Severe Asthma
- (2020) Nikolaos G. Papadopoulos et al. ALLERGY
- Staphylococcus aureus and its IgE-inducing Enterotoxins in Asthma: Current Knowledge
- (2020) Claus Bachert et al. EUROPEAN RESPIRATORY JOURNAL
- Adherence to Inhaled Corticosteroids and Clinical Outcomes in Mepolizumab Therapy for Severe Asthma
- (2020) Gráinne d'Ancona et al. EUROPEAN RESPIRATORY JOURNAL
- Evolution and function of interleukin-4 receptor signaling in adaptive immunity and neutrophils
- (2020) Lukas E. M. Heeb et al. GENES AND IMMUNITY
- Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation
- (2020) Hiroki Kabata et al. Mucosal Immunology
- Dupilumab: Basic aspects and applications to allergic diseases
- (2020) Kazuto Matsunaga et al. ALLERGOLOGY INTERNATIONAL
- Microbial Regulation of Enteric Eosinophils and Its Impact on Tissue Remodeling and Th2 Immunity
- (2020) Rodrigo Jiménez-Saiz et al. Frontiers in Immunology
- Type 2 immunity in the skin and lungs
- (2020) Cezmi A. Akdis et al. ALLERGY
- Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma
- (2020) Ioana Agache et al. ALLERGY
- Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life
- (2020) Bruno Sposato et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank
- (2020) Alexander G. Mathioudakis et al. Journal of Allergy and Clinical Immunology-In Practice
- The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database
- (2019) Arnaud Bourdin et al. Journal of Allergy and Clinical Immunology-In Practice
- Severe asthma in children—a review of definitions, epidemiology, and treatment options in 2019
- (2019) Husam Ahmed et al. PEDIATRIC PULMONOLOGY
- The use of biologics for immune modulation in allergic disease
- (2019) Willem van de Veen et al. JOURNAL OF CLINICAL INVESTIGATION
- Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases
- (2019) Ioana Agache et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapid Onset of Effect of Benralizumab on Morning Peak Expiratory Flow in Severe, Uncontrolled Asthma
- (2019) Geoffrey Chupp et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Cost-effectiveness and comparative effectiveness of biologic therapy for asthma
- (2019) William C. Anderson et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Precision Medicine for the discovery of treatable mechanisms in severe Asthma
- (2019) Kian Fan Chung et al. ALLERGY
- Towards clinically applicable biomarkers for asthma – An EAACI position paper
- (2019) Zuzana Diamant et al. ALLERGY
- Prioritising research challenges and funding for allergy and asthma and the need for translational research ‐ the European Strategic Forum on Allergic Diseases
- (2019) Ioana Agache et al. ALLERGY
- Severe asthma: entering an era of new concepts and emerging therapies: Highlights of the 4 th International Severe Asthma Forum, Madrid, 2018
- (2019) S F Seys et al. ALLERGY
- EAACI Guidelines on Allergen Immunotherapy: House dust mite‐driven allergic asthma
- (2019) Ioana Agache et al. ALLERGY
- EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitis
- (2019) Carina Venter et al. ALLERGY
- The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
- (2019) Kenneth R. Chapman et al. ALLERGY
- Disease burden in patients with asthma before initiating biologics: A retrospective cohort database study
- (2019) Hector Ortega et al. ALLERGY AND ASTHMA PROCEEDINGS
- Severe asthma in children
- (2019) Louise Selby et al. Current Opinion in Allergy and Clinical Immunology
- Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation
- (2019) John Efthimiou et al. EUROPEAN RESPIRATORY JOURNAL
- Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma
- (2019) I Dávila González et al. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
- Novel inhaled pan-JAK inhibitor, LAS194046, reduces allergen-induced airway inflammation, late asthmatic response and pSTATs activation in Brown Norway rats.
- (2019) Marta Calbet et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study
- (2019) Luis Pérez de Llano et al. RESPIRATORY MEDICINE
- IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states
- (2019) Giulia Pellizzari et al. EBioMedicine
- Efficacy of Mepolizumab in patients with previous Omalizumab treatment failure: real life observation
- (2019) Diego Bagnasco et al. ALLERGY
- Mechanisms and therapeutic strategies for Non‐T2 Asthma
- (2019) Eric Sze et al. ALLERGY
- Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling
- (2019) Mark Zak et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility
- (2019) Marc Humbert et al. RESPIRATORY MEDICINE
- Different endotypes and phenotypes drive the heterogeneity in severe asthma
- (2019) P. Jane McDowell et al. ALLERGY
- Evaluating direct costs and productivity losses of patients with asthma receiving GINA 4/5 therapy in the United States
- (2019) Russell A. Settipane et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Long-term evaluation of response to omalizumab therapy in real life by a novel multimodular approach
- (2019) Harjinder Singh et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Management of Severe Asthma: a European Respiratory Society/American Thoracic Society Guideline
- (2019) Fernando Holguin et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
- (2019) Claus Bachert et al. LANCET
- Severe asthma phenotypes and endotypes
- (2019) Ioana Agache SEMINARS IN IMMUNOLOGY
- Trends and Disparities in Asthma Biologic Use in the United States
- (2019) Jonathan W. Inselman et al. Journal of Allergy and Clinical Immunology-In Practice
- Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 Trials
- (2019) J. Christian Virchow et al. Journal of Allergy and Clinical Immunology-In Practice
- Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma
- (2019) Jonathan Corren et al. Journal of Allergy and Clinical Immunology-In Practice
- Mepolizumab and reslizumab, two different options for severe asthma patients with prior failure to omalizumab
- (2019) Luis A. Pérez de Llano et al. ALLERGY
- Development and initial validation of the Asthma Severity Scoring System (ASSESS)
- (2019) Anne M. Fitzpatrick et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Estimation of Health and Economic Benefits of Clinic Versus Home Administration of Omalizumab and Mepolizumab
- (2019) Marcus Shaker et al. Journal of Allergy and Clinical Immunology-In Practice
- Perspectives in allergen immunotherapy: 2019 and beyond
- (2019) Oliver Pfaar et al. ALLERGY
- An expert consensus framework for asthma remission as a treatment goal
- (2019) Andrew Menzies-Gow et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pharmacology and Therapeutics of Bronchodilators Revisited
- (2019) M. G. Matera et al. PHARMACOLOGICAL REVIEWS
- Immunologic mechanisms in asthma
- (2019) Tadech Boonpiyathad et al. SEMINARS IN IMMUNOLOGY
- Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients
- (2019) David Michalovich et al. Nature Communications
- The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
- (2019) Giancarlo Marone et al. Frontiers in Pharmacology
- Efficacy of an Inhaled Interleukin-13 Antibody Fragment in a Model of Chronic Asthma
- (2018) Daniel Lightwood et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab
- (2018) Manali Mukherjee et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma
- (2018) Bradley E. Chipps et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Nonadherence in the era of severe asthma biologics and thermoplasty
- (2018) Joy Lee et al. EUROPEAN RESPIRATORY JOURNAL
- Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study
- (2018) Marc Humbert et al. EUROPEAN RESPIRATORY JOURNAL
- Asthma across the lifespan: Time for a paradigm shift
- (2018) Stanley J. Szefler JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab
- (2018) Michelle A. Gill et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Sputum autoantibodies in patients with severe eosinophilic asthma
- (2018) Manali Mukherjee et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Monitoring inflammatory heterogeneity with multiple biomarkers for multidimensional endotyping of asthma
- (2018) Ioana Agache et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The IL-33/ST2 axis is crucial in type 2 airway responses induced by Staphylococcus aureus –derived serine protease–like protein D
- (2018) Andrea R. Teufelberger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Elevated Expression of IL-33 and TSLP in the Airways of Human Asthmatics In Vivo: A Potential Biomarker of Severe Refractory Disease
- (2018) Yan Li et al. JOURNAL OF IMMUNOLOGY
- Epithelial damage and tissue γδ T cells promote a unique tumor-protective IgE response
- (2018) Greg Crawford et al. NATURE IMMUNOLOGY
- Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
- (2018) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
- (2018) Mario Castro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bronchial Thermoplasty in Severe Asthma: Best Practice Recommendations from an Expert Panel
- (2018) Peter I. Bonta et al. RESPIRATION
- Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life
- (2018) Dinh S Bui et al. Lancet Respiratory Medicine
- Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes
- (2018) Ilkka S. Junttila Frontiers in Immunology
- Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age
- (2018) W. Gerald Teague et al. Journal of Allergy and Clinical Immunology-In Practice
- Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study
- (2018) Thomas B. Casale et al. Journal of Allergy and Clinical Immunology-In Practice
- IgE deficiency and prior malignancy: results of the 2005-2006 National Health and Nutrition Examination Survey (NHANES)
- (2018) Denisa Ferastraoaru et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodies
- (2018) Sathyadevi Venkataramani et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Endotypes of severe allergic asthma patients who clinically benefit from anti-IgE therapy
- (2018) Yu-Chen Huang et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment
- (2018) Stephanie Chen et al. CURRENT MEDICAL RESEARCH AND OPINION
- Omalizumab dampens type 2 inflammation in a group of long term treated asthma patients and detaches IgE from FcεRI
- (2018) Laura Maggi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Bronchial Allergen Challenge of Patients with Atopic Asthma Triggers an Alarmin (IL-33, TSLP, and IL-25) Response in the Airways Epithelium and Submucosa
- (2018) Wei Wang et al. JOURNAL OF IMMUNOLOGY
- A multicentre, randomised, double-blind, placebo-controlled, crossover study to investigate the efficacy, safety, tolerability and pharmacokinetics of repeat doses of inhaled nemiralisib in adults with persistent, uncontrolled asthma
- (2018) Sanjeev Khindri et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Current State and Future of Biologic Therapies in the Treatment of Asthma in Children
- (2018) Elissa M. Abrams et al. Pediatric Allergy Immunology and Pulmonology
- Recent developments and highlights in mechanisms of allergic diseases: Microbiome
- (2018) Nonhlanhla Lunjani et al. ALLERGY
- Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper
- (2018) Franziska Roth-Walter et al. ALLERGY
- Sorting Out Nonadherence and Airway Inflammation in Treatment Escalation for Severe Asthma
- (2018) Bruce G Bender AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Les patients de la cohorte IDEAL : une photographie de l’asthme sévère en France
- (2018) C. Taillé et al. REVUE DES MALADIES RESPIRATOIRES
- Care pathways for the selection of a biologic in severe asthma
- (2017) Jean Bousquet et al. EUROPEAN RESPIRATORY JOURNAL
- Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma
- (2017) Maria Gabriella Matera et al. Expert Opinion on Drug Metabolism & Toxicology
- Innate and adaptive type 2 immunity in lung allergic inflammation
- (2017) Masato Kubo IMMUNOLOGICAL REVIEWS
- Role of IL-13 Genetic Variants in Signalling of Asthma
- (2017) Madhavi Latha Alasandagutti et al. INFLAMMATION
- Management of severe asthma: targeting the airways, comorbidities and risk factors
- (2017) Peter G. Gibson et al. INTERNAL MEDICINE JOURNAL
- Therapeutic efficacy of a co-blockade of IL-13 and IL-25 on airway inflammation and remodeling in a mouse model of asthma
- (2017) Fang-Qi Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies
- (2017) Óscar Palomares et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function
- (2017) Cecilia K. Andersson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Combined blockade of the IL-13 and IL-33 pathways leads to a greater inhibition of type 2 inflammation over inhibition of either pathway alone
- (2017) Vladimir Ramirez-Carrozzi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics
- (2017) Phillip L. Lieberman et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial
- (2017) Peter G Gibson et al. LANCET
- Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma
- (2017) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tezepelumab in Adults with Uncontrolled Asthma
- (2017) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Childhood severe asthma: New insights on remodelling and biomarkers
- (2017) Sejal Saglani Paediatric Respiratory Reviews
- Omalizumab could be effective in children with severe eosinophilic non-allergic asthma
- (2017) M. Bourgoin-Heck et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Local amplifiers of IL-4Rα–mediated macrophage activation promote repair in lung and liver
- (2017) Carlos M. Minutti et al. SCIENCE
- Asthma Biomarkers: Do They Bring Precision Medicine Closer to the Clinic?
- (2017) Ioana Agache et al. Allergy Asthma & Immunology Research
- Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
- (2017) Geoffrey L Chupp et al. Lancet Respiratory Medicine
- Trends in Omalizumab Utilization for Asthma: Evidence of Suboptimal Patient Selection
- (2017) Molly M. Jeffery et al. Journal of Allergy and Clinical Immunology-In Practice
- Altered Epithelial Gene Expression in Peripheral Airways of Severe Asthma
- (2017) Akul Singhania et al. PLoS One
- Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics
- (2016) I. Agache et al. ALLERGY
- Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma
- (2016) Jonathan Corren et al. CHEST
- Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels
- (2016) Leif Bjermer et al. CHEST
- Pathways through which asthma risk factors contribute to asthma severity in inner-city children
- (2016) Andrew H. Liu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia
- (2016) Steven G. Smith et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Type 2 innate lymphoid cells in induced sputum from children with severe asthma
- (2016) Prasad Nagakumar et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3–like protein 1
- (2016) Timothy S.C. Hinks et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents
- (2016) Jacqueline A. Pongracic et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Lung-resident eosinophils represent a distinct regulatory eosinophil subset
- (2016) Claire Mesnil et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
- (2016) Eugene R Bleecker et al. LANCET
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
- (2016) Sally Wenzel et al. LANCET
- Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) J Mark FitzGerald et al. LANCET
- Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma
- (2016) Michael J. McGeachie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Qualitative effects of omalizumab on concomitant IgE-mediated disease in a severe asthmatic population: a real life observational study
- (2016) R.P. Cusack et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Trained immunity: A program of innate immune memory in health and disease
- (2016) M. G. Netea et al. SCIENCE
- Endotypes of allergic diseases and asthma: An important step in building blocks for the future of precision medicine
- (2016) Ioana Agache et al. ALLERGOLOGY INTERNATIONAL
- Efficacy and Safety of Anti-Interleukin-5 Therapy in Patients with Asthma: A Systematic Review and Meta-Analysis
- (2016) Fa-Ping Wang et al. PLoS One
- EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders
- (2015) O. Boyman et al. ALLERGY
- Immunity to Helminths: Resistance, Regulation, and Susceptibility to Gastrointestinal Nematodes
- (2015) Richard K. Grencis Annual Review of Immunology
- Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium
- (2015) B. Rup et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The Eosinophil in Infection
- (2015) Karen A. Ravin et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside
- (2015) Ioana Agache et al. CURRENT ALLERGY AND ASTHMA REPORTS
- IL-4 and IL-13 signaling in allergic airway disease
- (2015) Naina Gour et al. CYTOKINE
- The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts
- (2015) Louise Fleming et al. EUROPEAN RESPIRATORY JOURNAL
- Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations
- (2015) Stephen J. Teach et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The prevalence of severe refractory asthma
- (2015) Pieter-Paul W. Hekking et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
- (2015) Mario Castro et al. Lancet Respiratory Medicine
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploring the Effects of Omalizumab in Allergic Asthma
- (2013) Nicola A. Hanania et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy
- (2013) Nicola A. Hanania et al. ANNALS OF INTERNAL MEDICINE
- From phenotypes to endotypes to asthma treatment
- (2013) Ioana O. Agache Current Opinion in Allergy and Clinical Immunology
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
- (2013) K. F. Chung et al. EUROPEAN RESPIRATORY JOURNAL
- Omalizumab Attenuates Airway Inflammation and Interleukin-5 Production by Mononuclear Cells in Patients with Severe Allergic Asthma
- (2013) Yotaro Takaku et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
- (2013) Michel Laviolette et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- High eosinophil count: A potential biomarker for assessing successful omalizumab treatment effects
- (2013) William Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma
- (2013) Sejal Saglani et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effects of Omalizumab in Non-Atopic Asthma: Results from a Spanish Multicenter Registry
- (2013) Luis Pérez de Llano et al. JOURNAL OF ASTHMA
- Mechanisms of Allergen-Specific Immunotherapy and Novel Ways for Vaccine Development
- (2013) Marek Jutel et al. ALLERGOLOGY INTERNATIONAL
- Untangling asthma phenotypes and endotypes
- (2012) I. Agache et al. ALLERGY
- Omalizumab: An update on efficacy and safety in moderate-to-severe allergic asthma
- (2012) Bradley E. Chipps et al. ALLERGY AND ASTHMA PROCEEDINGS
- The expanding role(s) of eosinophils in health and disease
- (2012) E. A. Jacobsen et al. BLOOD
- Development and validation of the Composite Asthma Severity Index—an outcome measure for use in children and adolescents
- (2012) Jeremy J. Wildfire et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pediatric severe asthma is characterized by eosinophilia and remodeling without TH2 cytokines
- (2012) Cara J. Bossley et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection
- (2012) Fei Chen et al. NATURE MEDICINE
- Reslizumab for Poorly Controlled, Eosinophilic Asthma
- (2011) Mario Castro et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications
- (2011) Raed A. Dweik et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
- (2011) Jan Lötvall et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
- (2011) Gordon Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- A Complement-IL-4 Regulatory Circuit Controls Liver Regeneration
- (2011) R. A. DeAngelis et al. JOURNAL OF IMMUNOLOGY
- Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
- (2011) William W. Busse et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of omalizumab on IgE-induced cytokine synthesis by asthmatic airway smooth muscle cells
- (2010) Michael Roth et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
- (2010) Roland Kolbeck et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Counterregulation between the Fc RI Pathway and Antiviral Responses in Human Plasmacytoid Dendritic Cells
- (2010) M. A. Gill et al. JOURNAL OF IMMUNOLOGY
- Omalizumab-induced decrease of FcɛRI expression in patients with severe allergic asthma
- (2010) Pascal Chanez et al. RESPIRATORY MEDICINE
- Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
- (2009) Wendy C. Moore et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
- (2009) Bob Lanier et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of omalizumab on peripheral blood eosinophilia in allergic asthma
- (2009) M. Massanari et al. RESPIRATORY MEDICINE
- Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment
- (2008) E. L. J. van Rensen et al. ALLERGY
- Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease
- (2008) Gary P Anderson LANCET
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now